AURORA, CO--(MARKET WIRE)--Jun 26, 2007 -- Vitro Diagnostics, Inc. (OTC BB:VODG.OB - News), dba Vitro Biopharma, announced the development of a new method to derive human pancreatic beta islets from adult pancreatic stem cells. Through research and development of stem cell differentiation methods, Vitro discovered a process that yields islets that appear structurally equivalent to those derived from the pancreas gland. These islets are produced in high yield and exhibit properties comparable to native islets including expression and secretion of biomarkers for insulin.
